Skip to content

Randomised controlled study of fundoplication or medical treatment for gastro-oesophageal reflux in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN82683558
Enrollment
455
Registered
2004-01-23
Start date
2000-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive system diseases: Other digestive system disease Digestive System Gastro-Oesophageal Reflux (GORD)

Interventions

Fundoplication vs medical management

Sponsors

NHS R&D Regional Programme Register - Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children aged less than 16 years with clinical evidence of gastro-oesophageal reflux. Phase One - 250 to 330. Phase Two - 115 to 125.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Body weight Z scores.

Secondary

MeasureTime frame
1. Continuing or recurrent gastro-oesophageal reflux 2. Complication rate after fundoplication, ECA on EGG 3. Validated quality of life score for patients and parents

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026